Podoplanin (PDPN, M2A Antigen) (D2-40)Catalogue number: PDP001-0.5
This antibody is well suited for the detection of podoplanin in histological sections and cells. Podoplanin is a highly glycosylated glycoprotein (162 AS, 36 kDa) that is predominantly expressed on lymphatic endothelia. Therefore antibodies against podoplanin are often used as a marker for lymphatic vessels. Podoplanin is a protein that is also found on podocytes of the kidney glomeruli (therefore the name podoplanin) and in fetal testis. Since a while podoplanin is considered as a good marker for the malign pleuramesothelioma and is used for differential diagnosis of this disease (Ordonèz, 2005). Normally podoplanin occurs in lymphatic vessels, placenta, lung, and skeletal muscles. Appearance in testicular germ cells, lymphangioma and lymphangiosarcoma is noticeable. In haemangioma und other diseases of the vessels overexpression of the glycoprotein is not found. Podoplanin, M2A Antigen of lymphatic endothelia.
Immunogen: M2A Antigen, Podoplanin
Affinity purified antibody in PBS, BSA, NaN3
Purification Method: Affinity purified antibody in PBS, BSA, NaN3
Secondary Reagents: Anti-mouse IgG:Biotin conjugate (code no. ZU102) in combination with Streptavidin-HRPO (code no. ZU054) and a suitable substrate e.g. DAB (Ref. DA002) or AEC (Ref AE002).
Species Reactivity: Human, other species not tested
Working Concentration: (liquid conc.) 1:30-1:100
Pre-Treatment: The best pre-treatment of paraffin sections has not been validated at our lab. Meanwhile we suggest the usage of routine heat induced antigen retrieval although some laboratory results were positive without any unmasking.
Positive Control: Lymph nodes, Germ cell tumors
These antibodies are intended for in vitro research use only. They must not be used for clinical diagnostics and not for in vivo experiments in humans or animals. The preservative sodium azide has been added in very small quantities. Nevertheless, it may be harmful to health and the reagent should be used only by trained personnel. For waste disposal, please refer to national regulations.
1. Hiroaki Yokomori Masaya Oda, Fumihiko Kaneko, Shigeyuki Kawachi, Minoru Tanabe, Kazunori Yoshimura, Yuko Kitagawa, and Toshifumi Hibi Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities Gastroenterology 2010, 10:131 2. Annette M. Müller, Folker E. Franke, Klaus-Michael Müller (2006) D2-40: A Reliable Marker in the Diagnosis of Pleural Mesothelioma Pathobiology 73:50-54 3. Yu H, Pinkus GS, Hornick JL. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms. Am J Clin Pathol. 2007 Nov;128(5):767-75. 4. Qingmei Xie, Lugen Chen, Kai Fu, Josephine Harter, Ken H Young, Jaya Sunkara, Deborah Novak, Esperanza Villanueva-Siles, and Howard Ratech (2008) Podoplanin (D2-40): A New Immunohistochemical Marker for Reactive Follicular Dendritic Cells and Follicular Dendritic Cell Sarcomas Int J Clin Exp Pathol. 1(3): 276–284. 5. Nelson G. Ordóñez (2005) D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma Human Pathol. 36(4) 372-380
Database Name: UniProt
Accession number: Q86YL7 (PDPN_HUMAN)
Species Accession: Human
Podoplanin (PDPN, M2A Antigen) (D2-40)